When Ali Mousavi and Arash Helmi joined the Startup Visa program sponsored by Nova Scotia venture capital Crown corporation Innovacorp, it was not from their home country of Iran, but thanks to a South Korean startup competition.

Mousavi and Helmi are the co-founders of Magic Organ Cloner, or MOC Biotechnologies. In 2019, they were in Korea to compete in the BIXPO innovation conference’s

Talks are now under way between Innovacorp and the Nova Scotia government about what should be done with the $104 million that Innovacorp received from its investment in Metamaterials Inc.

Last week, Entrevestor reported that the Nova Scotia government’s early-stage venture capital agency made a return of $101 million on its $3 million investment in META. That’s a total return of 35 times, and a

Startup accelerator Creative Destruction Lab’s oceans stream has joined Virginia-based industry group Ocean Visions to offer training to startups gunning for the Carbon Removal XPRIZE -- a cleantech startup competition with a US$100 million prize, funded by Tesla CEO Elon Musk.

Creative Destruction Lab and Ocean Visions will offer a specially tailored program to XPRIZE entrants, helping them

Ocean Startup Project has announced 22 participating teams have been accepted into the second year of the Lab2Market Oceans program, which aims to produce commercial applications for academic research.

Lab2Market Oceans teams comprise researchers from academic institutions, as well as faculty supervisors and industry mentors. The teams work with instructors who provide feedback and coaching

Halifax advanced materials startup 3D BioFibR has raised $700,000 in what it describes as an “oversubscribed follow-on round,” marking the company’s second six-figure raise since its founding last year.

3D BioFibR was incorporated in July, 2020 and had raised $550,000 by October of the same year. The most recent round included capital from Halifax’s Concrete Ventures and Toronto’s Globalive

Halifax drugmaker Appili Therapeutics has raised US$1 million from FUJIFILM Toyama Chemical Co. to pay for ongoing clinical trials of the Japanese pharma giant’s favipiravir antiviral medication, which the two companies hope will prove useful in treating COVID-19.

Favipiravir, sold under the names Avigan and Reeqonus, was approved for use in treating influenza pandemics by the Japanese

Halifax’s Union.Dev is deploying its pension-management software at a 30,000-person union in Ontario and has raised $310,000 of non-dilutive funding from NRC IRAP and the Atlantic Canada Opportunities Agency.

The company’s software, dubbed the Pension Reporting System, grew out of contract work that co-founder Randy Ansems was hired to do in 2012 by a third-party company offering pension

Sponsored Content

Two years ago at the University of New Brunswick, a group of faculty, students and alumni began to toss around an idea: could artificial intelligence (AI) help regulators trace the movement of cryptocurrencies and prevent crime? 

Dr. Dhirendra Shukla was talking to entrepreneur-in-residence Sandy Bird, co-founder of cybersecurity pioneer Q1 Labs, about this idea when he found

Innovacorp has cashed in on its investment in Metamaterials Inc., banking a gain of $101 million and making a return of almost 35 times.

Nova Scotia’s provincial venture capital Crown corporation invested a total of $3.1 million in 2015 and 2017 in Meta, as it’s now known, a Dartmouth-based maker of advanced materials that can alter light. Meta listed on the Canadian Securities Exchange two